- Home
- ALT vs KRNY Comparison
ALT vs KRNY Comparison
Compare ALT & KRNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALT
- KRNY
- Stock Information
- Founded
- ALT 1997
- KRNY 1884
- Country
- ALT United States
- KRNY United States
- Employees
- ALT N/A
- KRNY N/A
- Industry
- ALT Biotechnology: Pharmaceutical Preparations
- KRNY Savings Institutions
- Sector
- ALT Health Care
- KRNY Finance
- Exchange
- ALT Nasdaq
- KRNY Nasdaq
- Market Cap
- ALT 472.3M
- KRNY 450.4M
- IPO Year
- ALT N/A
- KRNY 2005
- Fundamental
- Price
- ALT $4.55
- KRNY $5.92
- Analyst Decision
- ALT Strong Buy
- KRNY Buy
- Analyst Count
- ALT 8
- KRNY 2
- Target Price
- ALT $21.00
- KRNY $7.75
- AVG Volume (30 Days)
- ALT 2.2M
- KRNY 426.3K
- Earning Date
- ALT 05-08-2025
- KRNY 04-24-2025
- Dividend Yield
- ALT N/A
- KRNY 7.56%
- EPS Growth
- ALT N/A
- KRNY N/A
- EPS
- ALT N/A
- KRNY N/A
- Revenue
- ALT $20,000.00
- KRNY $148,070,000.00
- Revenue This Year
- ALT N/A
- KRNY $17.60
- Revenue Next Year
- ALT N/A
- KRNY $22.31
- P/E Ratio
- ALT N/A
- KRNY N/A
- Revenue Growth
- ALT N/A
- KRNY N/A
- 52 Week Low
- ALT $3.55
- KRNY $5.28
- 52 Week High
- ALT $11.16
- KRNY $8.59
- Technical
- Relative Strength Index (RSI)
- ALT 43.21
- KRNY 43.00
- Support Level
- ALT $4.32
- KRNY $5.55
- Resistance Level
- ALT $4.75
- KRNY $5.91
- Average True Range (ATR)
- ALT 0.38
- KRNY 0.29
- MACD
- ALT 0.05
- KRNY 0.01
- Stochastic Oscillator
- ALT 63.22
- KRNY 51.65
About ALT Altimmune Inc.
Altimmune Inc is engaged in developing treatments for obesity and liver diseases. The Company's pipeline includes next-generation peptide therapeutics for obesity and non-alcoholic steatohepatitis (NASH) (for both, pemvidutide, formerly known as ALT-801), and for chronic hepatitis B (HepTcell). The Company is managed and operates as a single business focused on the research and development of treatments for various diseases and disorders, and vaccines.
About KRNY Kearny Financial Corp
Kearny Financial Corp is a federally-chartered stock savings bank. The bank is engaged in the business of attracting deposits from the general public in New Jersey and New York, and using these deposits, together with other funds, to originate or purchase loans for its portfolios and invest in securities. The bank's loan portfolio is chiefly comprised of loans collateralized by commercial and residential real estate. It is also heavily into secured and unsecured business and consumer loans. The bank's primary source of income is net interest income.